Thread by @Molecule_dao

1/ Today, we are excited to announce that we have raised $12.7M in seed funding. 🌱

The round was led by @npv_vc with participation from 60+ other visionary biotech & web3 investors.

Read the full story here: molecule.to/blog/we-have-r…

2/ We’re incredibly grateful for the follow-on investment from our pre-seed investors who participated in this round: @inflectionvc, @AndrewDARMACAP, James Brodie & @AminoCollective

We are now one step closer to creating a more equitable future for researchers and patients.

3/ The biopharma industry has come a long way, however, an ecosystem remains where potentially impactful research goes unfunded, and incentives for collaboration are often missing.

4/ We aim to address these incentive problems and funding gaps by creating an open ecosystem that assists researchers in raising funds for impactful research projects in a community-driven way.

5/ “Scientific research today suffers from a myriad of funding and intermediation issues, making it a ripe candidate for disruption by blockchain-based infrastructure…”

6/ “We’re incredibly excited for Molecule to improve capital & social coordination for the massive life science industry by enabling markets for drug development and turning all stages of intellectual property into liquid assets.” - @lalleclausen, Founding Partner @1kxnetwork

7/ With Molecule, diverse communities (including patient groups, researchers, universities, charities, as well as VCs and pharma companies) can fund, own and govern therapeutic intellectual property.

8/ This provides novel incentives for collaboration, investment, and risk-sharing. The result is that communities, such as patient groups, can choose which projects get funded, and later own the therapeutics that treat their disease.

9/ “Many of the most impactful therapeutics are discovered in academic labs, yet development and translation of these assets toward the clinic remains difficult. Molecule’s marketplace and IP-NFT framework will address many of the pain points inherent in the funding and...”

10/ “...commercialization of early-stage biotech IP, ultimately benefiting the most important stakeholder in the Molecule ecosystem – the patient. Northpond is excited to partner with Molecule and lead their seed round.” - @patricksmalone, MD PhD, Associate at @npv_vc.

11/ Our hope is that DeSci will provide a Copernican shift in access to therapeutics, of similar magnitude to what DeFi has become for traditional finance.

Labs that have already leveraged our DeSci infrastructure include @TheFangGroupUiO @ScheibyeKnudsen and @VIKorolchuk.

12/ We are honored to welcome some of the leading minds to Molecule and the DeSci ecosystem: @patricksmalone, @ShineCapitalNYC @mokoyfman, @ethqdaly, @1kxnetwork, @fiftyyears, @TheLAOOfficial @BackedVC, @ZeePrimeCap @Fiskantes, @L1Digital_, @amiloski, @chrisleiter

13/ A big thank you to all our pre-seed supporters @lunar_vc, @inflectionvc, @signature_vc, @AminoCollective, @AndrewDARMACAP, @PossibleVC, @nitinsharma1 and the entire @vita_dao core team and community. Thank you for your trust, we couldn't have done it without you!💙

14/ A massive thanks as well to the following investors: @seedclubvc, @insideNiMA, @antavedissian, IdTheory @LankyID, @CompoundVC, @pillar_vc, @protocollabs, @BoxGroup, @KdT_Ventures @benjileibo, @balajis, @pierskicks.

Full list below👇

15/ @KetanYerneni, @mackhealy @CmanMD @phil_j_grayeski, @RChakraba, @uddinym, @AndrewDARMACAP, @ceeceeboom, @GaingelsVC, @CherryVentures, @aminocollective, @OrangeDAOxyz, @gelenbe, @chorusone, @KindergartenVC, @speedinvest, @BoolCapital (@valentalb @hendrikhofstadt @leolukde)

16/ @QwQiao, @crainbf, @notscottmoore, @pbanhardt @allisondman, @meherroy, @ajayoup, @angelomint, @StakeETH, @bitcoingarrett, @licuende, @ronjonnag, @aloktayi, @longevion, @koji_capital, @DToddWhite

17/ @timrpeterson, @laurensdp, @healthspancap, @sebastian_gero, @AndrewSteinwold, @TimSchlidt, @olshav, @accelmed & @krdonnelly

18/ Want to join the DeSci Renaissance? Here is everything you need: linktr.ee/molecule_to

19/ Also check out this thread by our CEO, @paulkhls to see his point of view:

https://twitter.com/paulkhls/status/1541486216830492673?s=20&t=qesyi2dhNC8nXMmmff1vZg

20/ And our CSO, @GolatoTyler 🧬

https://twitter.com/GolatoTyler/status/1487007194054893570?s=20&t=qesyi2dhNC8nXMmmff1vZg